Schizophrenia, substance abuse and immigration
DOI:
https://doi.org/10.25118/2763-9037.2013.v3.358Abstract
.
Downloads
Metrics
References
Wobrock T, Soyka M. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1375-85. DOI: https://doi.org/10.1016/j.pnpbp.2008.02.008
Green AI, Noordsy DL, Brunette MF, O’Keefe C. Substance abuse and schizophrenia: pharmacotherapeutic intervention. J Subst Abuse Treat. 2008;34:61-71. Epub 2007 Jun 15. DOI: https://doi.org/10.1016/j.jsat.2007.01.008
Laqueille X, Launay C, Kanit M. [Induced psychiatric and somatic disorders to cannabis] Ann Pharm Fr. 2008;66:245-54. Epub 2008 Sep 4. DOI: https://doi.org/10.1016/j.pharma.2008.06.001
Coulston CM, Perdices M, Tennant CC. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. Aust N Z J Psychiatry. 2007;4:869-84. DOI: https://doi.org/10.1080/00048670701634952
Green AI. Schizophrenia and comorbid substance use disorder: effects of antipsychotics. J Clin Psychiatry. 2005; 66: 21-6.
Cantor-Graae E. The contribution of social factors to the development of schizophrenia: a review of recent findings. Can J Psychiatry. 2007; 52:277-86. DOI: https://doi.org/10.1177/070674370705200502
Palomo T, Archer T, Kostrzewa RM, Beninger RJ. Comorbidity of substance abuse with other psychiatric disorders. Neurotox Res. 2007;12:17-27. DOI: https://doi.org/10.1007/BF03033898
Le Bec PY, Fatséas M, Denis C, Lavie E, Auriacombe M. [Cannabis and psychosis: search of a causal link through a critical and systematic review] Encephale. 2009;35:77-85. Epub 2008 Jul 9. DOI: https://doi.org/10.1016/j.encep.2008.02.012
DeLisi LE. The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Curr Opin Psychiatry. 2008:21:140-50. DOI: https://doi.org/10.1097/YCO.0b013e3282f51266
Wobrock T, Soyka M. Pharmacotherapy of patients with schizophrenia and substance abuse. Expert Opin Pharmacother. 2009;10:353-67. 11. Realini N, Rubino T, Parolaro D. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacol Res. 2009;60:132-8. Epub 2009 Mar 17 DOI: https://doi.org/10.1016/j.phrs.2009.03.006
Cantor-Graae E, Selten JP. Schizophrenia andmigration: a meta-analysis and review. Am J Psychiatry. 2005:162:12-24 DOI: https://doi.org/10.1176/appi.ajp.162.1.12
Selten JP, Cantor-Graae E, Kahn RS. Migration and schizophrenia. Curr Opin Psychiatry. 2007;20:111-5 DOI: https://doi.org/10.1097/YCO.0b013e328017f68e
Murthy P, Chand P. Treatment of dual diagnosis disorders. Curr Opin Psychiatry. 2012: 25:194-200. DOI: https://doi.org/10.1097/YCO.0b013e328351a3e0
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
